Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MannKind Corp.

www.mannkindcorp.com

Latest From MannKind Corp.

Will Primatene Mist Inventory Ever Leave The Warehouse?

Amphastar has inventory for the emergency asthma product but is frustrated by the recent second complete response letter from US FDA seeking additional information. Human factors issued figured into CRLs for both Primatene Mist and intranasal naloxone.

Consumer Complete Response Letters

Nanobiotix Expands US Leadership Team

Nanobiotix has made two new appointments – one related to clinical development and the other to investor relations – to its US team.

Cancer Appointments

APPOINTMENT ROUND UP: GlaxoSmithKline, Sanofi, Immune Design, Clinigen, Advaxis, Nanobiotix and Kite Pharma

This week's round up includes CEO appointments by GSK, who has appointed Brian McNamara CEO of the company's consumer unit, Clinigen and The Grünenthal Group; and executive appointments by Sanofi, where Alan Main has joined as executive vice president consumer healthcare global business unit, Immune Design, Advaxis, Kite Pharma and Bavarian Nordic.

Appointments

PIPELINE WATCH: Three Approvals, Three Filings And Two Launches

This week's Pipeline Watch, a snapshot of all the late-stage R&D and regulatory events in the pharma and biotech industries, is now available to view.

Research & Development Pipeline Watch
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
  • Pharmaceuticals
    • Drug Delivery
      • Pulmonary
  • Therapeutic Areas
  • Cancer
  • Metabolic Disorders
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • MannKind Corp.
  • Senior Management
  • Matthew J Pfeffer, CEO & CFO
    Hakan S Edstrom, Pres. & COO
  • Contact Info
  • MannKind Corp.
    Phone: (661) 775-5300
    25134 Rye Canyon Loop
    Suite 300
    Valencia, CA 91355
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register